2026 ICD-10-CM Diagnosis Code Z12.5Encounter for screening for malignant neoplasm of prostate

ICD-10-CM Codes›Z00–Z99›Z00-Z13›Z12

ICD-10-CM Z12.5
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

Z12.5 is a billable ICD-10-CM diagnosis code for encounter for screening for malignant neoplasm of prostate. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasm-related encounters.

This medical diagnosis code is frequently used in Family Practice medical specialties to designate conditions such general medical examination.

Code Identity

ICD-10-CM Code
Z12.5
Billable Status
Yes — Valid for Submission
Code Describes
Encounter for screening for malignant neoplasm of prostate
Short Description
Encounter for screening for malignant neoplasm of prostate
Same as the full description in the CMS dataset.
Parent Code
Z12
Encounter for screening for malignant neoplasms

Code Classification

ChapterZ00–Z99Factors influencing health status and contact with health services
SectionZ00-Z13Persons encountering health services for examinations
CategoryZ12Encounter for screening for malignant neoplasms
This CodeZ12.5Encounter for screening for malignant neoplasm of prostate

Present on Admission (POA)Billing

Z12.5 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Screening(for)
      • neoplasm (malignant) (of)
        • genitourinary organs NEC
          • prostate
    • Screening(for)
      • neoplasm (malignant) (of)
        • prostate

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR FAC008
Neoplasm-related encounters
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Prostate Cancer Screening

Cancer is a disease when the cells of the body grow out of control. Cancer screening is having tests to look for signs of cancer before you have any symptoms. By the time cancer causes symptoms, it may have already spread to other parts of your body. A screening test may help find cancer early, when it may be easier to treat.

The full article covers:

  • What is cancer screening?
  • What is prostate cancer screening?
  • What tests screen for prostate cancer?
  • What are the possible benefits and harms of prostate cancer screening?
  • Should I be screened for prostate cancer?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert Z12.5 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
V76.44 Scrn malig neop-prostate
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About Z12.5Overview

Is Z12.5 (Encounter for screening for malignant neoplasms) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report encounter for screening for malignant neoplasm of prostate on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is Z12.5 exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for encounter for screening for malignant neoplasm of prostate on inpatient claims.

What is the ICD-9 equivalent of Z12.5?

Under the General Equivalence Mappings, encounter for screening for malignant neoplasm of prostate converts to ICD-9-CM V76.44 (scrn malig neop-prostate). The mapping is a direct match.